FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称DOCARAVIMAB
异名/同义词62-71-3
DOCARAVIMAB
DOCARAVIMAB [INN]
DOCARAVIMAB [WHO-DD]
IMMUNOGLOBULIN G2, ANTI-(RABIES VIRUS STRAIN EVELYN-ROCKITNIKI-ABELSETH GLYCOPROTEIN ECTODOMAIN EPITOPE G-III) (MUS MUSCULUS MONOCLONAL .GAMMA.2-CHAIN), DISULFIDE WITH MUS MUSCULUS MONOCLONAL .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G2B, ANTI-(RABIES VIRUS STRAIN EVELYN-ROCKITNIKI-ABELSETH GLYCOPROTEIN ECTODOMAIN EPITOPE G-III) (MUS MUSCULUS MONOCLONAL 62-71-3 .GAMMA.2B-CHAIN), DISULFIDE WITH MUS MUSCULUS MONOCLONAL 62-71-3 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G2B-KAPPA, ANTI-(RABIES VIRUS STRAINERA (EVELYN-ROCKITNIKI-ABELSETH) GLYCOPROTEIN ECTODOMAIN EPITOPE G-III), MUS MUSCULUS MONOCLONAL ANTIBODY
CAS登记号2247196-23-0
物质唯一标识(Unique Ingredient Identifier)I0HK032RR6
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System